WeChat Mini Program
Old Version Features

OA15.05 HUDSON: an Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

B. Besse,M.M. Awad,P.M. Forde,M. Thomas,G. Goss,B. Aronson,R. Hobson,E. Dean,J. Peters,S. Iyer,J. Conway,J.C. Barrett,J. Cosaert,M. Dressman,S.T. Barry,J.V. Heymach

Journal of Thoracic Oncology（2022）

Cited 2|Views20
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined